Breakthrough Research Presented by Weill Cornell Ophthalmologists at the 2008 Annual Meeting of the Retina Society

Dr. Donald J. D'Amico, Professor and Chairman of Ophthalmology at Weill Cornell Medical College, Ophthalmologist-in-Chief at NewYork-Presbyterian Hospital/Weill Cornell Medical Center and the current President of the Retina Society presented data on a combination treatment strategy for age-related macular degeneration targeting platelet-derived growth factor along with vascular endothelial growth factor at the 2008 Annual Meeting of the Retina Society in Scottsdale, Arizona.

Dr. Szilárd Kiss, Assistant Professor of Ophthalmology at Weill Cornell Medical College, presented work on an intraocular gene delivery approach to the treatment of neovascular diseases including diabetic retinopathy and age-related macular degeneration.

Dr. R.V. Paul Chan, the St. Giles Assistant Professor of Pediatric Retina and Assistant Professor of Ophthalmology at Weill Cornell Medical College, described risks for progression of retinopathy of prematurity.

Next year, New York City will play host to Retina Congress 2009, a combined meeting of the American Society of Retina Specialists, Macula Society, and Retina Society.


Top of page